Bowling Green Sentinel Tribune Alzheimer's drug shows promise in early results of study Erie Shores • Sep 29, 2022
Northwest Signal | Napoleon Controversial Alzheimer's drug gets limited approval from Medicare Western Ohio • Apr 14, 2022
Northwest Signal | Napoleon Biogen Cuts Price of Controversial Aduhelm in Half Western Ohio • Dec 21, 2021
Northwest Signal | AG News Biogenic-carbon-dioxide barrier must be addressed Ohio Business • Dec 8, 2020